lobbying_activities: 2016731

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2016731	9baeb7a4-607a-4189-bfba-1dc9c41e2068	3T	CAPITOL COUNSEL LLC	313715	SANOFI US SERVICES INC	2017	third_quarter	HCR	Health care reform; drug safety, value and reimbursement; prevention, diagnosis and treatment of chronic disease; implementation of related provisions in the Affordable Care Act; value of prescription medicines; adult vaccines; pandemic and biodefense funding; Zika funding and countermeasure development; drug importation, including related provisions in H.R. 1245 and S. 469, the Affordable and Safe Prescription Drug Importation Act and S. 64, and H.R. 1480, the Safe and Affordable Drugs from Canada Act; and drug pricing and insulin pricing issues; and Buy American Act implementation issues.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	1	2017-07-28T15:04:28.647000-04:00